Top Markets
#1 COTI COTI +42.67%
#2 GALA GALA +33.41%
#3 Fabric Protocol Fabric Protocol +32.65%
#4 Magma Finance Magma Finance +29.45%
#5 Bitcoin Cash Bitcoin Cash +28.96%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +28.66%
#7 Tutorial Tutorial +27.51%
#8 Talus Network Talus Network +26.43%
#9 Zora Zora +24.71%
#10 Zcash Zcash +24.26%
Coin of the day
COTI COTI
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Miromatrix Medical Inc. Miromatrix Medical Inc.

Miromatrix Medical Inc.

MIRO
Kedudukan dalam Saham #24471
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a... Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.
Harga Saham
$3.39
Disegerakkan terakhir: 2023-12-22
Modal Pasaran
$60.24M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Miromatrix Medical Inc. (MIRO)

Kategori

Healthcare
Pendapatan untuk Miromatrix Medical Inc. (MIRO)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Miromatrix Medical Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Miromatrix Medical Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH